{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:22:29Z","timestamp":1785432149884,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Grant-in-Aids for Scientific Research from the Japanese Ministry of Education, Science, Sports, Technology and Culture","award":["22K06990"],"award-info":[{"award-number":["22K06990"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11060-023-04447-8","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:30:30Z","timestamp":1694723430000},"page":"633-641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas"],"prefix":"10.1007","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6645-7818","authenticated-orcid":false,"given":"Takuya","family":"Furuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-7513","authenticated-orcid":false,"given":"Tetsuya","family":"Negoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-0473","authenticated-orcid":false,"given":"Mayuko","family":"Moritsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2657-8604","authenticated-orcid":false,"given":"Jun","family":"Akiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4996-5279","authenticated-orcid":false,"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7250-457X","authenticated-orcid":false,"given":"Yasuo","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"4447_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"4447_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","volume":"65","author":"Y Rong","year":"2006","unstructured":"Rong Y, Durden DL, Van Meir EG, Brat DJ (2006) Pseudopalisading\u2019 necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 65:529\u2013539. https:\/\/doi.org\/10.1097\/00005072-200606000-00001","journal-title":"J Neuropathol Exp Neurol"},{"key":"4447_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/neuonc\/nos197","volume":"14","author":"JR Perry","year":"2012","unstructured":"Perry JR (2012) Thromboembolic disease in patients with high-grade glioma. Neuro Oncol 14:73\u201380. https:\/\/doi.org\/10.1093\/neuonc\/nos197","journal-title":"Neuro Oncol"},{"key":"4447_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00401-021-02401-4","volume":"143","author":"SM Markwell","year":"2022","unstructured":"Markwell SM, Ross JL, Olson CL, Brat DJ (2022) Necrotic reshaping of the glioma microenvironment drives disease progression. Acta Neuropathol 143:291\u2013310. https:\/\/doi.org\/10.1007\/s00401-021-02401-4","journal-title":"Acta Neuropathol"},{"key":"4447_CR5","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/neuonc\/now113","volume":"18","author":"E Eskilsson","year":"2016","unstructured":"Eskilsson E, Rosland GV, Talasila KM, Knappskog S, Keunen O, Sottoriva A, Foerster S, Solecki G, Taxt T, Jirik R, Fritah S, Harter PN, Valk K, Al Hossain J, Joseph JV, Jahedi R, Saed HS, Piccirillo SG, Spiteri I, Leiss L, Euskirchen P, Graziani G, Daubon T, Lund-Johansen M, Enger PO, Winkler F, Ritter CA, Niclou SP, Watts C, Bjerkvig R, Miletic H (2016) EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through src activation. Neuro Oncol 18:1644\u20131655. https:\/\/doi.org\/10.1093\/neuonc\/now113","journal-title":"Neuro Oncol"},{"key":"4447_CR6","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/s41388-017-0045-7","volume":"37","author":"Z An","year":"2018","unstructured":"An Z, Aksoy O, Zheng T, Fan QW, Weiss WA (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561\u20131575. https:\/\/doi.org\/10.1038\/s41388-017-0045-7","journal-title":"Oncogene"},{"key":"4447_CR7","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1038\/onc.2012.280","volume":"32","author":"CA Del Vecchio","year":"2013","unstructured":"Del Vecchio CA, Giacomini CP, Vogel H, Jensen KC, Florio T, Merlo A, Pollack JR, Wong AJ (2013) EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms. Oncogene 32:2670\u20132681. https:\/\/doi.org\/10.1038\/onc.2012.280","journal-title":"Oncogene"},{"key":"4447_CR8","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1158\/0008-5472.CAN-17-3551","volume":"78","author":"Z An","year":"2018","unstructured":"An Z, Knobbe-Thomsen CB, Wan X, Fan QW, Reifenberger G, Weiss WA (2018) EGFR cooperates with EGFRvIII to recruit macrophages in glioblastoma. Cancer Res 78:6785\u20136794. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3551","journal-title":"Cancer Res"},{"key":"4447_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00005","volume":"5","author":"E Padfield","year":"2015","unstructured":"Padfield E, Ellis HP, Kurian KM (2015) Current therapeutic advances targeting EGFR and EGFRvIII in Glioblastoma. Front Oncol 5:5. https:\/\/doi.org\/10.3389\/fonc.2015.00005","journal-title":"Front Oncol"},{"key":"4447_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"4447_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/00005072-199209000-00002","volume":"51","author":"SF Haddad","year":"1992","unstructured":"Haddad SF, Moore SA, Schelper RL, Goeken JA (1992) Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. J Neuropathol Exp Neurol 51:488\u2013492. https:\/\/doi.org\/10.1097\/00005072-199209000-00002","journal-title":"J Neuropathol Exp Neurol"},{"key":"4447_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/00005072-199505000-00003","volume":"54","author":"P Wesseling","year":"1995","unstructured":"Wesseling P, Schlingemann RO, Rietveld FJ, Link M, Burger PC, Ruiter DJ (1995) Early and extensive contribution of pericytes\/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol 54:304\u2013310. https:\/\/doi.org\/10.1097\/00005072-199505000-00003","journal-title":"J Neuropathol Exp Neurol"},{"key":"4447_CR13","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170","journal-title":"Bioinformatics"},{"key":"4447_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616","journal-title":"Bioinformatics"},{"key":"4447_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1750-3639.2007.00108.x","volume":"18","author":"M Tehrani","year":"2008","unstructured":"Tehrani M, Friedman TM, Olson JJ, Brat DJ (2008) Intravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioblastoma. Brain Pathol 18:164\u2013171. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00108.x","journal-title":"Brain Pathol"},{"key":"4447_CR16","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.3390\/ijms24043169","volume":"24","author":"D Pastori","year":"2023","unstructured":"Pastori D, Cormaci VM, Marucci S, Franchino G, Del Sole F, Capozza A, Fallarino A, Corso C, Valeriani E, Menichelli D, Pignatelli P (2023) A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci 24:3169. https:\/\/doi.org\/10.3390\/ijms24043169","journal-title":"Int J Mol Sci"},{"key":"4447_CR17","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.ejso.2018.07.052","volume":"44","author":"Y Lin","year":"2018","unstructured":"Lin Y, Liu Z, Qiu Y, Zhang J, Wu H, Liang R, Chen G, Qin G, Li Y, Zou D (2018) Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: a systematic review and meta-analysis. Eur J Surg Oncol 44:1494\u20131503. https:\/\/doi.org\/10.1016\/j.ejso.2018.07.052","journal-title":"Eur J Surg Oncol"},{"key":"4447_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13019-021-01618-4","volume":"16","author":"M Ma","year":"2021","unstructured":"Ma M, Cao R, Wang W, Wang B, Yang Y, Huang Y, Zhao G, Ye L (2021) The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis. J Cardiothorac Surg 16:243. https:\/\/doi.org\/10.1186\/s13019-021-01618-4","journal-title":"J Cardiothorac Surg"},{"key":"4447_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1200\/JCO.2000.18.3.600","volume":"18","author":"K Blackwell","year":"2000","unstructured":"Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, Iglehart JD, Dewhirst M, Greenberg C (2000) Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol 18:600\u2013608. https:\/\/doi.org\/10.1200\/JCO.2000.18.3.600","journal-title":"J Clin Oncol"},{"key":"4447_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3171\/2018.7.JNS181175","volume":"132","author":"L Rinaldo","year":"2019","unstructured":"Rinaldo L, Brown DA, Bhargav AG, Rusheen AE, Naylor RM, Gilder HE, Monie DD, Youssef SJ, Parney IF (2019) Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature. J Neurosurg 132:10\u201321. https:\/\/doi.org\/10.3171\/2018.7.JNS181175","journal-title":"J Neurosurg"},{"key":"4447_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/01.jnen.0000235118.75182.94","volume":"65","author":"T Homma","year":"2006","unstructured":"Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S, Ohgaki H (2006) Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 65:846\u2013854. https:\/\/doi.org\/10.1097\/01.jnen.0000235118.75182.94","journal-title":"J Neuropathol Exp Neurol"},{"key":"4447_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cell.2013.02.021","volume":"153","author":"L Cheng","year":"2013","unstructured":"Cheng L, Huang Z, Zhou W, Wu Q, Donnola S, Liu JK, Fang X, Sloan AE, Mao Y, Lathia JD, Min W, McLendon RE, Rich JN, Bao S (2013) Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 153:139\u2013152. https:\/\/doi.org\/10.1016\/j.cell.2013.02.021","journal-title":"Cell"},{"key":"4447_CR23","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/neuonc\/nox191","volume":"20","author":"E Eskilsson","year":"2018","unstructured":"Eskilsson E, Rosland GV, Solecki G, Wang Q, Harter PN, Graziani G, Verhaak RGW, Winkler F, Bjerkvig R, Miletic H (2018) EGFR heterogeneity and implications for therapeutic intervention in glioblastoma. Neuro Oncol 20:743\u2013752. https:\/\/doi.org\/10.1093\/neuonc\/nox191","journal-title":"Neuro Oncol"},{"key":"4447_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2176\/nmc.oa.2018-0078","volume":"59","author":"T Nozawa","year":"2019","unstructured":"Nozawa T, Okada M, Natsumeda M, Eda T, Abe H, Tsukamoto Y, Okamoto K, Oishi M, Takahashi H, Fujii Y, Kakita A (2019) EGFRvIII is expressed in cellular areas of tumor in a subset of glioblastoma. Neurol Med Chir (Tokyo) 59:89\u201397. https:\/\/doi.org\/10.2176\/nmc.oa.2018-0078","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"4447_CR25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood-2009-10-250639","volume":"116","author":"N Magnus","year":"2010","unstructured":"Magnus N, Garnier D, Rak J (2010) Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells. Blood 116:815\u2013818. https:\/\/doi.org\/10.1182\/blood-2009-10-250639","journal-title":"Blood"},{"key":"4447_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bbrc.2014.10.041","volume":"454","author":"N Magnus","year":"2014","unstructured":"Magnus N, Meehan B, Garnier D, Hashemi M, Montermini L, Lee TH, Milsom C, Pawlinski R, Ohlfest J, Anderson M, Mackman N, Rak J (2014) The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis. Biochem Biophys Res Commun 454:262\u2013268. https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.041","journal-title":"Biochem Biophys Res Commun"},{"key":"4447_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tonjes M, Sill M, Bender S, Kool M, Zapatka M, Becker N, Zucknick M, Hielscher T, Liu XY, Fontebasso AM, Ryzhova M, Albrecht S, Jacob K, Wolter M, Ebinger M, Schuhmann MU, van Meter T, Fruhwald MC, Hauch H, Pekrun A, Radlwimmer B, Niehues T, von Komorowski G, Durken M, Kulozik AE, Madden J, Donson A, Foreman NK, Drissi R, Fouladi M, Scheurlen W, von Deimling A, Monoranu C, Roggendorf W, Herold-Mende C, Unterberg A, Kramm CM, Felsberg J, Hartmann C, Wiestler B, Wick W, Milde T, Witt O, Lindroth AM, Schwartzentruber J, Faury D, Fleming A, Zakrzewska M, Liberski PP, Zakrzewski K, Hauser P, Garami M, Klekner A, Bognar L, Morrissy S, Cavalli F, Taylor MD, van Sluis P, Koster J, Versteeg R, Volckmann R, Mikkelsen T, Aldape K, Reifenberger G, Collins VP, Majewski J, Korshunov A, Lichter P, Plass C, Jabado N, Pfister SM (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425\u2013437. https:\/\/doi.org\/10.1016\/j.ccr.2012.08.024","journal-title":"Cancer Cell"},{"key":"4447_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, Okelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98\u2013110. https:\/\/doi.org\/10.1016\/j.ccr.2009.12.020","journal-title":"Cancer Cell"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04447-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T13:05:41Z","timestamp":1697807141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04447-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4447"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04447-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"5 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was performed in accordance with the principles of the Declaration of Helsinki and was approved by the Kurume University Medical Ethics Committee (No. 23063).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}